Concepedia

Asisa Volz

AV

33

Publications

1.7K

Citations

20

H-Index

2011

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

German Center for Infection Research

University of Veterinary Medicine Hannover, Foundation

Philipps University of Marburg

Medizinische Hochschule Hannover

Asisa Volz is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2011–2025

33

Publications

33

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

Bart L. Haagmans, Judith M. A. van den Brand, V. Stalin Raj et al. · Science · 2015 · 259 citations · Full text

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Till Koch, Christine Dahlke, Anahita Fathi et al. · The Lancet Infectious Diseases · 2020 · 166 citations · Full text

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

Asisa Volz, Alexandra Kupke, Fei Song et al. · Journal of Virology · 2015 · 158 citations · Full text

Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies

Fei Song, Robert Fux, Lisette B. Provacia et al. · Journal of Virology · 2013 · 148 citations · Full text

, , +12

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde et al. · Proceedings of the National Academy of Sciences · 2021 · 96 citations · Full text

Rows per page

1–5 of 33